Sunflower Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 59.5% in First Half of 2023

Sunflower Pharmaceutical Group Co.,Ltd. (葵花药业集团股份有限公司) (002737.SZ) reported a net profit of 678.9 million yuan in the first half of 2023, up 59.5% year-on-year.

Meanwhile, the company posted 3 billion yuan in revenue, up 34.9% year-on-year.

At the end of the reporting period, it had 6.5 billion yuan in total assets and 2 billion yuan in total liabilities, with a liability-to-asset ratio of 30.7%.